Literature DB >> 25609732

A pilot evaluation of external quality assessment of GenoType MTBDRplus versions 1 and 2 using dried culture spot material.

N Gous1, L E Isherwood2, A David2, W Stevens3, L E Scott4.   

Abstract

Dried culture spots (DCS) of inactivated Mycobacteria strains designed as part of an external quality assessment (EQA) program for the GeneXpert system has applications to other molecular tuberculosis (TB) diagnostic platforms. DCS tested on the GenoType MTBDRplus and Mycobacterium CM assays performed well with MTBDRplus version 2 but require increased bacterial concentration for use with version 1.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Year:  2015        PMID： 25609732      PMCID： PMC4365260          DOI： 10.1128/JCM.03340-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa.

Authors:  L E Scott; N Gous; B E Cunningham; B D Kana; O Perovic; L Erasmus; G J Coetzee; H Koornhof; W Stevens
Journal:  J Clin Microbiol       Date:  2011-10-05       Impact factor: 5.948

2.  Performance monitoring of mycobacterium tuberculosis dried culture spots for use with the GeneXpert system within a national program in South Africa.

Authors:  N Gous; B Cunningham; B Kana; W Stevens; L E Scott
Journal:  J Clin Microbiol       Date:  2013-09-25       Impact factor: 5.948

Review 3.  Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.

Authors:  Linda M Parsons; Akos Somoskövi; Cristina Gutierrez; Evan Lee; C N Paramasivan; Alash'le Abimiku; Steven Spector; Giorgio Roscigno; John Nkengasong
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

4.  Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Authors:  Danica Helb; Martin Jones; Elizabeth Story; Catharina Boehme; Ellen Wallace; Ken Ho; JoAnn Kop; Michelle R Owens; Richard Rodgers; Padmapriya Banada; Hassan Safi; Robert Blakemore; N T Ngoc Lan; Edward C Jones-López; Michael Levi; Michele Burday; Irene Ayakaka; Roy D Mugerwa; Bill McMillan; Emily Winn-Deen; Lee Christel; Peter Dailey; Mark D Perkins; David H Persing; David Alland
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

5.  Multicenter feasibility study to assess external quality assessment panels for Xpert MTB/RIF assay in South Africa.

Authors:  Lesley Scott; Heidi Albert; Chris Gilpin; Heather Alexander; Kyle DeGruy; Wendy Stevens
Journal:  J Clin Microbiol       Date:  2014-04-30       Impact factor: 5.948

6.  Characteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy.

Authors:  Stephen D Lawn; Andrew D Kerkhoff; Monica Vogt; Yonas Ghebrekristos; Andrew Whitelaw; Robin Wood
Journal:  Clin Infect Dis       Date:  2012-02-07       Impact factor: 9.079
  6 in total
  3 in total

1.  Genetic Mimetics of Mycobacterium tuberculosis and Methicillin-Resistant Staphylococcus aureus as Verification Standards for Molecular Diagnostics.

Authors:  Edith Erika Machowski; Bavesh Davandra Kana
Journal:  J Clin Microbiol       Date:  2017-09-20       Impact factor: 5.948

2.  South Africa's experience with provision of quality HIV diagnostic services.

Authors:  Natasha M Gous; Leigh Berrie; Patience Dabula; Wendy Stevens
Journal:  Afr J Lab Med       Date:  2016-10-17

3.  External quality assessment in resource-limited countries.

Authors:  Jane Y Carter
Journal:  Biochem Med (Zagreb)       Date:  2017-02-15       Impact factor: 2.313
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.